SVB Wealth LLC Invests $12.02 Million in UnitedHealth Group Incorporated (NYSE:UNH)

SVB Wealth LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 23,752 shares of the healthcare conglomerate’s stock, valued at approximately $12,015,000.

A number of other large investors have also made changes to their positions in the stock. Waterway Wealth Management LLC raised its holdings in UnitedHealth Group by 10.5% in the 4th quarter. Waterway Wealth Management LLC now owns 631 shares of the healthcare conglomerate’s stock valued at $319,000 after acquiring an additional 60 shares in the last quarter. Fortress Financial Group LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at $499,000. Davis Rea LTD. boosted its stake in UnitedHealth Group by 31.2% during the fourth quarter. Davis Rea LTD. now owns 23,438 shares of the healthcare conglomerate’s stock worth $11,856,000 after buying an additional 5,575 shares in the last quarter. First American Bank raised its stake in shares of UnitedHealth Group by 2.9% in the 4th quarter. First American Bank now owns 42,634 shares of the healthcare conglomerate’s stock valued at $21,567,000 after buying an additional 1,187 shares in the last quarter. Finally, Parkside Financial Bank & Trust boosted its position in shares of UnitedHealth Group by 1.8% during the 4th quarter. Parkside Financial Bank & Trust now owns 5,971 shares of the healthcare conglomerate’s stock valued at $3,020,000 after acquiring an additional 107 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $474.95 on Friday. The firm has a market cap of $437.09 billion, a price-to-earnings ratio of 30.64, a PEG ratio of 1.37 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a 50-day moving average price of $516.59 and a 200 day moving average price of $557.16.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period last year, the firm earned $5.83 earnings per share. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be paid a $2.10 dividend. The ex-dividend date is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.77%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. 0.33% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of recent research reports. Truist Financial decreased their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Wells Fargo & Company cut their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Barclays dropped their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.